Low procalcitonin, community acquired pneumonia, and antibiotic therapy - Authors' reply

Lancet Infect Dis. 2018 May;18(5):497-498. doi: 10.1016/S1473-3099(18)30226-3.

Authors

Philipp Schuetz¹, Angela Branche², Beat Mueller³

Affiliations

¹ Medical University Department, Kantonsspital Aarau, CH-5001 Aarau, Switzerland; Faculty of Medicine, University of Basel, Switzerland. Electronic address: schuetzph@gmail.com.
² University of Rochester School of Medicine, Rochester, NY, USA.
³ Medical University Department, Kantonsspital Aarau, CH-5001 Aarau, Switzerland; Faculty of Medicine, University of Basel, Switzerland.

PMID: 29695360
DOI: 10.1016/S1473-3099(18)30226-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Community-Acquired Infections*
Humans
Pneumonia*
Procalcitonin

Substances

Anti-Bacterial Agents
Procalcitonin